Balancing intellectual monopoly privileges and the need for essential medicines

Greg Martin; Corinna Sorenson; Thomas Faunce

doi:10.1186/1744-8603-3-4

Balancing intellectual monopoly privileges and the need for essential medicines

Greg Martin^*
, Corinna Sorenson
, Thomas Faunce

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

9 Citations (Scopus)

Abstract

This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions.

Original language	English
Article number	4
Journal	Globalization and Health
Volume	3
DOIs	https://doi.org/10.1186/1744-8603-3-4
Publication status	Published - 12 Jun 2007

Access to Document

10.1186/1744-8603-3-4

Cite this

@article{0e09b0315d7c4afbb564bfd91d5936b8,

title = "Balancing intellectual monopoly privileges and the need for essential medicines",

abstract = "This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions.",

author = "Greg Martin and Corinna Sorenson and Thomas Faunce",

year = "2007",

month = jun,

day = "12",

doi = "10.1186/1744-8603-3-4",

language = "English",

volume = "3",

journal = "Globalization and Health",

issn = "1744-8603",

publisher = "BioMed Central (BMC)",

}

TY - JOUR

T1 - Balancing intellectual monopoly privileges and the need for essential medicines

AU - Martin, Greg

AU - Sorenson, Corinna

AU - Faunce, Thomas

PY - 2007/6/12

Y1 - 2007/6/12

N2 - This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions.

AB - This issue of Globalization and Health presents a paper by Kerry and Lee that considers the TRIPS agreement and the recent policy debate regarding the protection of public health interest, particularly as they pertain to the Doha Declaration. In this editorial, we consider the debate, the conclusions thereof, and identify five questions that should be considered by key stakeholders in ongoing discussions.

UR - https://www.scopus.com/pages/publications/34447309719

U2 - 10.1186/1744-8603-3-4

DO - 10.1186/1744-8603-3-4

M3 - Editorial

SN - 1744-8603

VL - 3

JO - Globalization and Health

JF - Globalization and Health

M1 - 4

ER -

Balancing intellectual monopoly privileges and the need for essential medicines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this